More Evidence of Clock Gene Dysfunction from Virus. Implications for Chronic Fatigue Syndrome and Other Diseases!
It has been reported from past studies that the clock gene
is disrupted in chronic fatigue syndrome but how this occurs is unknown. The clock gene regulates circadian
rhythms mammals and controls proteins that regular regulate daily cycles, like sleep/wake
cycles and feeding. It has been proposed that secondary messengers
also control circadian rhythms. In mammals, a group of neurons that form a
structure called the suprachiasmatic nucleus (SCN) is known as the master
clock. This is in the hypothalamus and controls biological clock functions in peripheral
tissue. In a new study, scientists looked at how cAmp and calcium can influence
circadian rhythms, which was previously unclear. As the author writes, "cAMP
is a molecule that is important for many cellular functions." These scientists
found that by blocking a neural network, the cAMP function was lost. By doing
the same thing to calcium ions, the rhythms not lost and therefore, it was
demonstrated that calcium is regulated by intracellular mechanisms. Next, they
focused on the extracellular peptide called vasoactive intestinal peptide (VIP),
which has been known to modulate cAMP. The experiment demonstrated that when
VIP was blocked the rhythm of cAMP was also blocked. They also showed that VIP
is regulated by a circadian rhythm and this regulation was controlled by a neural
network. Lastly, the scientists determined that manipulation of cAmp with
external stimuli already known to alter cAmp functioning, it changed the
circadian rhythm of the clock gene and changed behavior. These results “suggest
that intracellular cAMP affects both molecular and behavioral circadian
rhythms involving the clock gene. It was concluded," intracellular cAMP
rhythms in the SCN are regulated by a VIP -dependent neural network." (1)
In past reports, many people have claimed that CFS developed
after a virus, and it has been proposed that subsequent dysbiosis may influence
its symptoms. Well, a recent study shows that it in mice after infection VIP
decreased in a cytokine-dependent manner. (If this is true, what happens when there is a chronic cytokine response?) In addition, a supplemental VIP
administration alleviated some of the deficits in the resulting mitochondrial
function and ATP caused by inflammatory mediators. According to the author, “improvements
in mitochondrial function and epithelial protection was due to VIP associated
reduction in oxidative stress. However,
treatment with VIP did not alter infection outcome.
It is now known that VIP- controlled biological function in
the intestine may influence physiological homeostasis which it is believed to
be altered in CFS. What happens when there is a deficiency of VIP in the gut?
Well, it has now been demonstrated to reduce a healthy diversity of the
microbiome and illustrates that VIP has an important role in controlling the
composition of the gut microbiota. One study showed the changes included a depletion
in “good bacteria” and an increase in “bad bacteria” in the microbiome that
resembled one associated with inflammatory disorders like IBD. In addition, there was a reduction in butyrate-producing
firmicutes. (3) Recently, a study showed a butyrate deficiency in CFS. Maybe,
just maybe, the loss of communication between VIP neural circadian control is
further disrupted after alterations of CFS microbiome. It is apparent that VIP
is an anti-inflammatory mediator but also has been noted that VIP can be
inflammatory as well. This may be due to VIP is present in so many different tissues
“including epithelial, the nerves, and the endocrine and immune systems. VIP
contributes to important physiological functions including anion secretion,
regulation of permeability of epithelial type junctions, mucosal inflammation,
glycemic control, Th1 and Th2 balance and tumor growth. Currently, VIP has been
suggested as a therapeutic target for conditions such as diarrhea, IBD,
diabetes, autoimmune diseases, neurodegenerative disorders, lung disease and
cancer. It is also used to treat mold toxicity and the resulting chronic
inflammatory immune response syndrome (CIRS). VIP treatment may also be used to
treat autoimmune rheumatoid arthritis.” (4)
Search for more on this blog! #CFS #dysbiosis #CLOCK Gene
1) 1) Clockwork Biology: cAMP Molecules illuminate
Circadian Rhythm mysteries. Nagoya University Sctechdaily.com September 1,
2023.
2) 2) Maiti AK, Sharba S, Navabi N, Lindén SK.
Colonic levels of vasoactive intestinal peptide decrease during infection and
exogenous VIP protects epithelial mitochondria against the negative effects of
IFNγ and TNFα induced during Citrobacter rodentium infection. PLoS One. 2018
Sep 25;13(9):e0204567. doi: 10.1371/journal.pone.0204567. PMID: 30252907;
PMCID: PMC6155558.
3) 3) Bains M, Laney C, Wolfe AE, Orr M, Waschek JA,
Ericsson AC, Dorsam GP. Vasoactive Intestinal Peptide Deficiency Is Associated
With Altered Gut Microbiota Communities in Male and Female C57BL/6 Mice. Front
Microbiol. 2019 Dec 2;10:2689. doi: 10.3389/fmicb.2019.02689. PMID: 31849864;
PMCID: PMC6900961.
4) 4) Iwasaki M, Akiba Y, Kaunitz JD. Recent advances
in vasoactive intestinal peptide physiology and pathophysiology: focus on the
gastrointestinal system. F1000Res. 2019 Sep 12;8:F1000 Faculty Rev-1629. doi:
10.12688/f1000research.18039.1. PMID: 31559013; PMCID: PMC6743256.

Comments
Post a Comment